0228 GMT - Raffles Medical Group's near-term earnings outlook appears weaker, Jefferies analyst Joanna Cheah says in a report. The healthcare provider's 1H results missed the bank's expectations owing to weaker occupancy at its Singapore hospitals and transitional care facilities, the analyst says. Reflecting softer occupancy trends in Singapore, Jefferies cuts its 2026-2028 earnings forecasts for the company by 10%-13% and lowers its target price on the stock to 1.10 Singapore dollars from S$1.30. However, Jefferies continues to see the stock's valuation as undemanding and maintains a buy rating. Shares are unchanged at S$0.91. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
July 27, 2026 22:28 ET (02:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.